发明名称 BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
摘要 The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.
申请公布号 US2017096485(A1) 申请公布日期 2017.04.06
申请号 US201615279799 申请日期 2016.09.29
申请人 Hoffmann-La Roche Inc. 发明人 BACAC Marina;FAUTI Tanja;FREIMOSER-GRUNDSCHOBER Anne;IMHOF-JUNG Sabine;KLEIN Christian;KLOSTERMANN Stefan;MOLHOJ Michael;NIEDERFELLNER Gerhard;REGULA Joerg Thomas;SCHAEFER Wolfgang;UMAÑA Pablo
分类号 C07K16/28 主分类号 C07K16/28
代理机构 代理人
主权项 1. A T cell activating bispecific antigen binding molecule comprising (a) a first antigen binding moiety which specifically binds to a first antigen; (b) a second antigen binding moiety which specifically binds to a second antigen; wherein the first antigen is an activating T cell antigen and the second antigen is mesothelin, or the first antigen is mesothelin and the second antigen is an activating T cell antigen; and wherein the antigen binding moiety which specifically binds to mesothelin comprises a heavy chain variable region, particularly a humanized heavy chain variable region, comprising the heavy chain complementarity determining region (HCDR) 1 of SEQ ID NO: 14, the HCDR 2 of SEQ ID NO: 15 and the HCDR 3 of SEQ ID NO: 16, and a light chain variable region, particularly a humanized light chain variable region, comprising the light chain complementarity determining region (LCDR) 1 of SEQ ID NO: 17, the LCDR 2 of SEQ ID NO: 18 and the LCDR 3 of SEQ ID NO: 19.
地址 Little Falls NJ US